All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis

BACKGROUND: Recently, the all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) protocol has become a promising first-line therapeutic approach in patients with newly diagnosed acute promyelocytic leukemia (APL), but its benefits compared with standard ATRA plus chemotherapy regimen needs to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yafang, Liu, Lu, Jin, Jie, Lou, Yinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938459/
https://www.ncbi.nlm.nih.gov/pubmed/27391027
http://dx.doi.org/10.1371/journal.pone.0158760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938459/
https://www.ncbi.nlm.nih.gov/pubmed/27391027
http://dx.doi.org/10.1371/journal.pone.0158760

Ejemplares similares